Clinical Trial Update: Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Fuzheng Huayu Tablets for posthepatitic cirrhosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Fuzheng Huayu Tablets

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Posthepatitic Cirrhosis | Phase 4 | Status: COMPLETED